VR for Steroid Joint Injections - Feasibility

NCT07778069 | Enrolling By Invitation

• 1 other identifier: STUDY00005875
• Study Type: interventional
• Target: 10
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of the project is to implement virtual reality for pain and anxiety management for patients undergoing intra-articular glucocorticoid injections in the outpatient pediatric rheumatology clinic.

Conditions

Acute Pain; Procedural Anxiety; Juvenile Idiopahtic Arthritis

Keywords

Virtual Reality; VR; JIA; Rheumatology

Outcome Measures

Primary Outcomes (1)

• Practicality/utility of the VR experience as a pain and anxiety management tool for IA joint injection procedures

  Assessed by the nurse answering the following questions: "Is this distraction tool helpful during joint injection procedures (Yes/No)?" and "Is this distraction tool easy to use during joint injections (Yes/No)?"

  Immediately following the IA joint injection procedure

Secondary Outcomes (2)

• Self-reported change procedural anxiety

  Immediately before the IA joint injection procedure and immediately after

• Self-reported pain

  Immediately following the IA joint injection procedure

Study Arms (1)

Intervention

EXPERIMENTAL

Participants will be using the VR-PAT during IA glucocorticoid injections

Other: VR-PAT

Interventions

VR-PAT OTHER

Virtual Reality Pain Alleviation Therapeutic (VR-PAT) via a Pico Neo3 Pro Eye

Intervention

Eligibility Criteria

• Age: 5 Years - 17 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• rheumatology patients (5-17 years old) who are undergoing an IA glucocorticoid injection in the Nationwide Children's Rheumatology Clinic,
• have a legal guardian present for patients less than 18 years old for the procedure (for informed consent), and
• can communicate orally.

You may not qualify if:

• any wounds that may interfere with study procedures,
• vision, hearing, or cognitive/motor impairments preventing valid administration of study measures,
• history of motion sickness, seizure disorder, dizziness, or migraine headaches precipitated by visual auras,
• minors in foster care,
• unable to communicate in English,
• pregnant women, or
• prisoners

Sponsors & Collaborators

• Nationwide Children's Hospital: lead

Study Sites (1)

Nationwide Children's Hospital

Columbus, Ohio, 43205, United States

Location

MeSH Terms

Conditions

Acute Pain

Condition Hierarchy (Ancestors)

Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor of Medicine and Center Director

Study Record Dates

• First Submitted: August 17, 2026
• First Posted: August 21, 2026
• Study Start: August 20, 2026
• Primary Completion (Estimated): July 1, 2029
• Study Completion (Estimated): December 1, 2029
• Last Updated: August 24, 2026

Record last verified: 2026-08

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)